Physician profile
Scott Anseth
NPI 1942213384
$9,869.84
in general payments reported to CMS, 2019-2025
11 companies · $1,342 in 2025
The $1,342 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,404 · 2020: $313 · 2021: $2,024 · 2022: $1,075 · 2023: $2,918 · 2024: $794 · 2025: $1,342.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,575 · Travel and Lodging: $1,479.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,575.29 |
| Travel and Lodging | $1,479.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $6,573.72 | 2019-2025 | Mako, Triathlon, Insignia |
| Conformis, INC. | $1,367.15 | 2020-2021 | |
| Smith+Nephew, INC. | $654.86 | 2019-2025 | Real Intelligence |
| Zimmer Biomet Holdings, INC. | $647.00 | 2019-2025 | G7, Rosa |
| Medtronic, INC. | $148.75 | 2025 | Aquamantys(Tm) |
| Depuy Synthes Sales INC. | $133.77 | 2022-2025 | |
| Medical Device Business Services, INC. | $128.87 | 2025 | Velys |
| Orthosensor INC. | $108.37 | 2019 | |
| Davol INC. | $107.35 | 2025 | Surgiphor |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$192,072.44 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Anseth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.